Related Experiment Video
Updated: Jun 27, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Investigating gout flares: beyond a definition.
Charles Sutherland1, Angelo L Gaffo2,3
1Tinsley Harrison Internal Medicine Residency Program.
Gout flares significantly impact patients, and recent studies have validated definitions and used technology to monitor them. Improved measurement methods are needed to fully capture the disease burden for better intervention development.
Area of Science:
- Rheumatology
- Clinical Trials
- Patient-Reported Outcomes
Background:
- Gout flares are a major contributor to the overall burden of gout for patients.
- Gout flares are recognized as a core domain for long-term gout studies by Outcome Measures in Rheumatology.
- Validated classification criteria for gout exist, prompting further investigation into defining and characterizing gout flares.
Purpose of the Study:
- To summarize efforts in defining and characterizing gout flares in clinical studies.
- To review recent advancements in gout flare assessment.
- To discuss the challenges and potential improvements in measuring gout flare burden.
Main Methods:
- Review of recent clinical studies and qualitative analyses.
- Examination of validated gout flare definitions.
- Assessment of technological applications for monitoring gout flares.
Main Results:
- A validated definition of a gout flare has been established and used in new clinical studies.
- Technology is being employed to monitor gout flares and their impact on patients' lives.
- Qualitative research has provided insights into the disease burden experienced by patients.
Conclusions:
- While core outcome domains are established, challenges remain in measuring and reporting gout flares in long-term trials.
- Current instruments may not fully capture the disease burden experienced by gout patients.
- Combining binary flare data with comprehensive, longitudinal disease burden measurements could enhance accuracy and aid intervention development.
Related Concept Videos
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

